Skip to main content

Table 2 Morphological values in different groups

From: Diagnostic capability of different morphological parameters for primary open‐angle glaucoma in the Chinese population

 

Global/Total

Infero-temporal

Supero-temporal

Temporal

Infero-nasal

Supero-nasal

Nasal

Controls(disc size < 2.43 mm2)

 BMO-MRW(µm)

288.8 ± 40.7

321.9 ± 53.3

291.6 ± 48.4

199.9 ± 37.5

356.7 ± 61.3

328.7 ± 62.4

308.9 ± 53.1

 BMO-MRA(mm2)

1.31 ± 0.23

0.17 ± 0.03

0.14 ± 0.03

0.23 ± 0.05

0.18 ± 0.37

0.16 ± 0.04

0.41 ± 0.08

 RNFL(µm)

104.4 ± 11.4

162 ± 20.5

139.1 ± 20.2

79.9 ± 12.2

119.7 ± 25.5

120.3 ± 28.1

79.8 ± 15.5

 Rim area(mm2)

1.37 ± 0.24

0.19 ± 0.05

0.17 ± 0.04

0.2 ± 0.05

0.22 ± 0.04

0.2 ± 0.05

0.38 ± 0.09

Controls(disc size > 2.43 mm2)

 BMO-MRW(µm)

256.9 ± 33.7a

296.9 ± 37.8a

258.7 ± 40.6a

180.6 ± 29.3a

322.9 ± 46.9a

300.6 ± 46.5a

262.9 ± 47.6a

 BMO-MRA(mm2)

1.36 ± 0.23

0.18 ± 0.03

0.14 ± 0.03

0.24 ± 0.05

0.19 ± 0.03

0.18 ± 0.03

0.41 ± 0.08

 RNFL(µm)

106.1 ± 9.3

164.8 ± 17.9

138.6 ± 21.3

75.7 ± 8.6

122.5 ± 22.1

131.5 ± 26.3

82.9 ± 10.9

 Rim area(mm2)

1.67 ± 0.32a

0.21 ± 0.06

0.2 ± 0.05a

0.22 ± 0.06

0.28 ± 0.06a

0.25 ± 0.06a

0.48 ± 0.13a

POAG

 BMO-MRW(µm)

191.4 ± 39.5b

168.6 ± 64.9b

180.8 ± 54.9b

148.2 ± 33.7b

211.9 ± 62.8b

228.1 ± 61.7b

218.4 ± 56.9b

 BMO-MRA(mm2)

0.95 ± 0.19b

0.1 ± 0.04b

0.1 ± 0.03b

0.18 ± 0.05b

0.12 ± 0.03b

0.12 ± 0.03b

0.32 ± 0.08b

 RNFL(µm)

75.6 ± 13.9b

84.9 ± 36.9b

93.6 ± 32.1b

62.3 ± 12.4b

85.5 ± 26.9b

96.7 ± 29.2b

65.6 ± 16.4b

 Rim area(mm2)

1.21 ± 0.37b

0.13 ± 0.07b

0.15 ± 0.06b

0.17 ± 0.08b

0.2 ± 0.07b

0.19 ± 0.06b

0.36 ± 0.12b

  1. BMO-MRW Bruch;s membrane opening-minimum rim width, BMO-MRA Bruch’s membrane opening-minimum rim area, RNFL retinal nerve fiber layer, POAG primary open-angle glaucoma
  2.  arepresent for statistical difference between controls with disc size < 2.43mm2 (macrodiscs) and controls with disc size > 2.43 mm
  3. brepresent for statistical difference between controls and POAG patients